Ann: HALFYR: TIL: Trilogy International announces 1H2016 revenue and profit

• Release Date: 25/11/15 08:30
• Summary: HALFYR: TIL: Trilogy International announces 1H2016 revenue and profit
• Price Sensitive: No
• Download Document  3.7KB

					TIL
25/11/2015 08:30
HALFYR
PRICE SENSITIVE
REL: 0830 HRS Trilogy International Limited

HALFYR: TIL: Trilogy International announces 1H2016 revenue and profit

Trilogy International announces 1H2016 revenue and profit results Growth in
revenue of 92% and earnings of 320% reflects strong performance in Australia
and New Zealand for skincare and fragrance brands.

Highlights:
- Revenue rises by $14.1m to $29.3m including the contribution of CS Company
of $5.16m
- Net profit before tax rises by $3.5m to $4.6m including CS Company
- Natural skincare delivered significant growth in Australia and New Zealand,
and is making good progress in the US and Asia.
- Home fragrance momentum continues across all markets, delivering favourable
results
- FY2016 revenue to reach $75m- $79m, and earnings before interest and tax
(EBIT) forecast to deliver within $12 million to $14 million

(See attachment)

International skin care and home fragrance products company Trilogy
International (NZX:TIL) today announces financial results and continued
progress in international markets.

Revenue for the six months to 30 September 2015 rose 92% to $29.3m from
$15.2m in the same period last year. Net profit before tax rose 320 % to
$4.6m from $1.1m.

Trilogy benefited from a strong performance in its home markets of Australia
and New Zealand and growth in Asia and the US. The half year also includes
the contribution of CS Company, a New Zealand cosmetics and fragrance
distribution business acquired in August.

Excluding the contribution from CS Company, Trilogy International's half year
revenue rose 58% to $24.2m, while net profit before tax rose 345% to $4.9m.

CS profit was affected by one off acquisition costs and adjustments, reducing
the H1 underlying operational performance.

Chairman Geoff Ross said: "We continue to be very pleased with the progress
the company is making both in its home markets and in its new markets further
afield. All businesses in the Trilogy
International portfolio are performing well."

Chief executive Angela Buglass said: "Demand for Trilogy International
products, and in particular our natural skin-care products, continues to
drive growth. We are pleased with the first half performance and the
increased momentum we are seeing across the portfolio.

Our New Zealand and Australian markets are continuing to perform above
expectations, reflecting a strong consumer following of the products.
Meanwhile, we continue to gain traction in our new emerging markets. They are
showing continuing signs of providing a promising platform for future
growth."

In line with guidance given at Trilogy International's annual meeting, the
company expects revenue for the year to 31 March 2016 to more than double to
between $75m and $79m, from $36.6m in the prior year. It also expects EBIT to
range between $12m and $14m, up from $4.9m in the prior year.

The amount of the full year dividend, in line with previous guidance, will be
announced after the year end results have been audited and published.

For more information:
Angela Buglass
Chief Executive Officer
+64 21 848 293
[email protected]
Geoff Ross Chairman
+64 21 42 219
[email protected]

About Trilogy International
Trilogy International (NZX:TIL) manufactures and distributes specialty
natural skin care and home fragrance products through three brands: Trilogy,
ECOYA and Goodness in New Zealand and around the world. Its recently acquired
subsidiary CS Company distributes international brands in New Zealand
including: Marc Jacobs; Calvin Klein; Dolce & Gabbana and Gucci fragrances
and Max Factor, Natio and OPI cosmetics and beauty brands.

For more information visit: http://trilogyproducts.com/investors/
End CA:00274011 For:TIL    Type:HALFYR     Time:2015-11-25 08:30:05